Docosahexaenoic acid protects against alcohol-induced constriction of cerebral arteries and inhibition of vascular smooth muscle BK channels. [PDF]
Thapa S +6 more
europepmc +1 more source
ABSTRACT Percutaneous transaxillary access is an established alternative to transfemoral large‐bore arterial access for transcatheter structural heart interventions and mechanical circulatory support (MCS). Although useful for overcoming hostile iliofemoral anatomy and providing prolonged support and patient mobilization in case of MCS, the axillary ...
Gioel Gabrio Secco +9 more
wiley +1 more source
On presentation of cerebral arteries via cortical openings. [PDF]
Nowinski WL.
europepmc +1 more source
Complex Cerebral Artery Anomaly Rete-like Formation of the Terminal Carotid and Middle Cerebral Arteries with Bilateral A1 Segments Fenestrations. [PDF]
Nestorovic D +5 more
europepmc +1 more source
Initial experiences of the Optima™ coil system in intracranial aneurysm treatment: surgical and interventional approach to safety and efficacy in terms of cerebral arteries. [PDF]
Ulusoy BSS +4 more
europepmc +1 more source
Accuracy of an nnUNet Neural Network for the Automatic Segmentation of Intracranial Aneurysms, Their Parent Vessels, and Major Cerebral Arteries from MRI-TOF. [PDF]
Colombo E +4 more
europepmc +1 more source
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri +12 more
wiley +1 more source
Feasibility of U-Net model for cerebral arteries segmentation with low-dose computed tomography angiographic images with pre-processing methods. [PDF]
Kang SH, Kim K, Shim J, Lee Y.
europepmc +1 more source
ANEURYSMS OF THE MIDDLE CEREBRAL ARTERY
E, CAMPBELL, C W, BURKLUND
openaire +3 more sources
Effects of SGLTi on Individual Clinical Endpoints and Quality‐of‐Life: outcome from randomized data. Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk factors.
Jia Liao +27 more
wiley +1 more source

